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Abstract Nicotine	 dependence	 is	 an	 addiction	 to	 tobacco	 products	 and	 a	 global	 public	 health	concern	that	in	part	would	be	influenced	by	our	genetics.	Smokers	are	reported	to	have	reduced	MAOA	activity,	but	the	results	from	genetic	associations	with	this	gene	have	been	inconclusive.	 Two	 functionally	 relevant	 variable	 number	 tandem	 repeat	 (VNTR)	domains,	 termed	 uVNTR	 and	 dVNTR,	 in	 the	 MAOA	 gene	 are	 well	 characterised	transcriptional	regulatory	elements.	In	the	present	study	we	analysed	uVNTR	and	dVNTR	polymorphisms	 in	 the	MAOA	gene	 in	 the	Vietnamese	male	population	of	smokers	and	non-smokers	in	order	to	assess	the	association	of	MAOA	with	the	nicotine	dependence	measured	by	the	Fagerström	Test	for	Nicotine	Dependence	(FTND).	Individual	analysis	of	VNTRs	separately	identified	uVNTR	to	be	associated	with	the	F6	question	of	the	FTND	indicating	 the	stronger	addiction	to	nicotine.	No	associations	were	 found	between	the	dVNTR	and	smoking	behaviour.	The	combination	of	dVNTR	and	uVNTR,	that	predicts	low	expression	 of	 MAOA	 (10-3	 haplotypes),	 was	 significantly	 associated	 with	 the	 higher	nicotine	 dependence	 (FTND	 score),	 longer	 smoking	 duration	 and	 more	 persistent	smoking	 behaviour	 (fewer	 quit	 attempts).	 In	 conclusion,	 our	 study	 confirms	 that	 low	MAOA	expression	is	genetically	predictive	to	the	higher	nicotine	dependence.	
Keywords:	 Variable	 Number	 Tandem	 Repeat	 (VNTR),	 MAOA,	 smoking,	 nicotine	dependence,	 Fagerström	 Test	 for	 Nicotine	 Dependence	 (FTND),	 Vietnam,	 genetic	interaction,	stratification		
Impact statement The	 present	 study	 combined	 analysis	 of	 two	 transcriptional	 regulators,	 uVNTR	 and	dVNTR,	in	the	MAOA	gene	that	is	an	enzyme	responsible	for	the	monoamine	degradation	and	identified	genetic	interaction	between	these	VNTRs	in	association	with	the	nicotine	dependence.	The	main	impact	is	that	when	analysing	different	populations	in	the	genetic	studies,	the	functionally	meaningful	variants	should	be	combined	rather	than	addressing	individual	elements	separately	(	a	mini	polygenic	risk	score	for	a	particular	gene/locus).	This	 combination	 is	 very	 rarely	 analysed	 and	 therefore	 the	 study	 sets	 an	 example.	Another	impact	is	that	we	analysed	the	genetic	variability	in	the	Asian	population	and	therefore	our	data	present	a	piece	of	information	from	underrepresented	populations.		 	
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Introduction 	Monoamine	 oxidase	 A	 (MAOA)	 is	 a	 member	 of	 the	 family	 of	 enzymes	 catalysing	 the	oxidative	 deamination	 of	 amines,	 such	 as	 dopamine,	 norepinephrine	 and	 serotonin	 1.	Humans	 have	 two	 enzymes,	 MAOA	 and	 MAOB,	 that	 are	 encoded	 by	 the	 tail-to-tail	arranged	 genes	 in	 the	X	 chromosome	 2,	 3.	 Both	 enzymes	 localise	 in	 the	mitochondrial	outer	 membrane.	 While	 both,	 MAOA	 and	 MAOAB	 inactivate	 monoamine	neurotransmitters,	 MAOA	 preferentially	 degrades	 serotonin,	 dopamine,	 melatonin,	norepinephrine	 and	 epinephrine	 4.	 This	 preference	 explains	 why	 MAOA	 has	 been	extensively	studied	in	the	context	of	behavioural	traits	and	psychiatric	diseases	5.			The	MAOA	gene	 is	 transcribed	 in	 two	main	protein	 coding	variants,	major	and	minor	isoforms	6.	In	its	promoter	and	5’UTR	region,	the	MAOA	gene	has	two	variable	number	tandem	repeats	(VNTRs)	that	regulate	differential	expression	of	these	two	isoforms	6.	The	proximal	VNTR,	uVNTR,	is	located	around	1.2	kb	upstream	of	one	of	the	transcriptional	start	sites	and	it	consists	of	a	repeated	30-bp	motif	that	can	be	present	in	2,	3,	3.5,	4	and	5	copies	7.	3.5	and	4	copy	versions	of	uVNTR	are	more	efficient	as	positive	regulators	and	MAOA	is	expressed	up	to	10-times	higher	than	with	other	uVNTR	variants	7.	Recently,	another	VNTR,	designated	as	a	dVNTR,	was	identified	1500	bp	upstream	of	the	ATG	site	8.	This	variant	is	a	10-bp	motif	that	can	exist	in	8,	9,	10	or	11	copies	and	these	variants	exhibit	differential	transcriptional	activity	8.	In	a	cell	line	model	the	9-copy	variant	is	the	most	active,	8	and	11	have	intermediate	activity	and	10	repeat	version	has	the	lowest	transcriptional	activity	8.	The	authors	of	this	initial	study	showed	that	dVNTR	could	have	a	 stronger	 regulatory	 function	 than	 uVNTR	 over	 MAOA	 expression.	 Indeed,	 this	 was	further	confirmed	in	an	independent	study	where	the	isoform	specific	effects	of	dVNTR	and	uVNTR	repeats	were	described	6.			Differences	 in	 the	MAOA	activity	or	expression	are	related	 to	 impulsivity,	behavioural	disturbances	and	addictive	disorders	9,	10	 .	MAOA	activity	 in	part	 is	determined	by	the	VNTR	genotypes	and	persons	with	the	low	activity	alleles	can	respond	with	violent	and	antisocial	behaviour	to	environmental	stress	11	.	Substance	abuse	could	be	a	result	of	the	anti-social	or	impulsive	behaviour	induced	by	the	stress.	The	most	prevalent	substance	abuse	is	tobacco	smoking	that	is	the	single	major	cause	for	premature	death	12.	Nicotine	
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Study design and participants The	details	of	the	study	cohort	have	been	described	in	our	previous	publications	16,	17.	Briefly,	it	is	a	community	based	cross-sectional	study	based	on	the	nicotine	dependence	survey	conducted	in	Da	Nang	and	Hue,	Vietnam.	The	cohort	consists	of	1,822	participants	(1,453	smokers	and	369	non-smokers).	Only	male	subjects	were	included	in	the	study	as	smoking	is	not	prevalent	in	women	in	Vietnam.	The	Ethics	Review	Committees	on	Human	Research	 of	 the	 University	 of	 Tartu,	 Da	 Nang	 University	 of	 Medical	 Technology	 and	Pharmacy	and	Hue	University	of	Medicine	 and	Pharmacy	approved	 the	protocols	 and	informed	consent	 forms	used	 in	 this	study.	All	participants	signed	a	written	 informed	consent	form	during	the	completion	of	the	questionnaire.		
Smoking data Smokers	were	defined	as	individuals	who	had	smoked	at	least	for	one	year.	Threshold	of	one	year	was	applied	to	enable	sufficient	time	for	development	of	nicotine	dependence	in	a	subject	and	this	excludes	the	persons	who	only	tried	occasionally	and	never	became	regular	smokers.	The	collected	data	was	then	inserted	into	the	Red-Cap	based	database	(https://www.project-redcap.org)	 18.	 RedCap	 is	 an	 abbreviation	 for	 the	 Research	Electronic	 Data	 CAPture	 and	 is	 an	 innovative	 software	 to	 support	 clinical	 and	translational	research.	RedCap	is	an	ideal	platform	for	similar	study	designs	as	it	allows	rapid	development	and	deployment	of	electronic	data	capture	which	can	be	used	 in	a	clinical	setting.	The	details	of	the	questionnaire	are	published	elsewhere	16.	Briefly	we	collected	 the	 information	 according	 to	 the	 FTND	 questionnaire	with	 some	 additional	general	questions	characterising	the	smoking	behaviour.		
Saliva collection and DNA extraction For	DNA	collection	and	extraction	Norgen	saliva	collection,	preservation	and	isolation	kit	(RU35700,	https://norgenbiotek.com)	was	used.	For	DNA	collection,	2	ml	of	saliva	was	mixed	 with	 the	 preservative	 reagent	 and	 DNA	 was	 extracted	 according	 to	 the	manufacturers	protocol	using	the	method	described	elsewhere	16	.		
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DNA genotyping Assays	for	genotyping	the	uVNTR	and	dVNTR	are	described	in	the	publication	of	Manca	et	 al.	 6	 Two	 separate	 polymerase	 chain	 reactions	 (PCR)	 were	 used	 along	 with	 two	different	primer	pairs	(Table	1)	to	amplify	uVNTR	(291	bp,	321	bp,	352	bop	and	381	bp)	and	dVNTR	(345	bp,	355	bp,	365	bp	and	375	bp)	 fragments.	For	 the	uVNTR	 the	 final	reaction	volume	 (20	ul)	 contained	1x	AmpliTaq	Gold	MasterMix	 (Applied	Biosystems,	California,	 CA)	 and	 oligonucleotide	 primers	 (TAG	 Copenhagen	 A/S)	 (Table	 1)	 at	 final	concentration	of	5	pmol	with	the	10	ng	of	gDNA.	Thermal	cycling	consisted	of	2	min	of	initial	denaturation	at	95oC	followed	by	35	cycles	of	95oC	(20s),	61oC	(20s)	and	72oC	(30s)	with	a	final	extension	step	of	5	min	at	72oC.	Subsequently,	10ul	of	PCR	product	was	loaded	onto	a	1.5%	agarose	gel,	run	for	1h	and	10	min	at	160V	in	TBE	and	visualized	by	ethidium	bromide.	For	the	dVNTR	the	final	reaction	volume	(20	ul)	contained	1x	Hot	FirePol	GC	Master	Mix	(Solis	 Biodyne,	 Tartu,	 Estonia),	 nucleotide	 mix	 with	 deaza-dGTP	 and	 oligonucleotide	primers	(TAG	Copenhagen	A/S)	(Table	1)	at	final	concentration	of	5	pmol	with	the	10	ng	of	gDNA.	Thermal	cycling	consisted	of	2	min	of	initial	denaturation	at	95oC	followed	by	10	cycles	of	95oC	(20s),	65-55oC	(20s)	and	72oC	(30s),	then	by	35	cycles	of	95oC	(20s),	55oC	(20s)	and	72oC	(30s)	with	a	final	extension	step	of	1	min	at	72oC.	Subsequently,	10ul	of	PCR	product	was	loaded	onto	a	2%	agarose	gel,	run	for	1h	and	10	min	at	160V	in	TBE	and	visualized	by	ethidium	bromide.		





uVNTR polymorphism uVNTR	was	polymorphic	in	our	cohort	with	four	different	variants:	2	,3,	4	and	5-repeats.	3-repeat	was	the	commonest	and	identified	in	922	subjects	(54	%).	The	4-repeat	was	the	second	commonest	with	765	subjects	 (44.5	%).	5-repeat	variant	was	detectable	 in	19	cases	(1	%)	and	2-repeat	variant	in	8	cases	(0.5	%).	As	the	5-	and	2-	repeats	were	very	rare	 and	 they	 are	 low	 expression	 variants	 as	 3-repeat	 variant,	we	 combined	 2	 and	 5	repeats	with	 the	 3-repeats	 for	 further	 analyses.	 This	 combination	 is	 necessary	 as	 the	variants	 with	 similar	 functional	 impact	 were	 combined	 and	 this	 way,	 we	 generated	biallelic	variants	that	are	most	commonly	used	by	genetic	association	studies.	The	variation	in	the	uVNTR	was	associated	with	the	question	F6	of	the	Fagerström	Test	for	Nicotine	Dependence,	 “Do	you	smoke	even	 if	you	are	sick	 in	bed	most	of	 the	day”.	Persons	with	the	3-repeat	allele	had	OR	1.4	(CI	1.1-1.8,	P	=	0.005)	to	smoke	when	sick	in	bed.	Therefore,	variant	with	the	low	MAOA	expression	increased	the	risk	for	to	be	more	addicted	for	smoking.	No	other	parts	of	the	smoking	behaviour	were	associated	with	the	variations	in	the	uVNTR.		
dVNTR polymorphism The	other	VNTR	in	our	study,	dVNTR,	was	also	polymorphic	in	our	cohort	with	8,	9,	10	and	11	 repeats	 as	 variants.	The	most	 common	variant	was	9-repeat	 variant	with	974	individuals	(55.3	%).	The	next	commonest	was	10-repeat	variant	that	was	found	on	778	subjects	(44.2	%).	The	11-repeat	was	identified	on	6	subjects	(0.3	%)	and	8-repeat	on	4	subjects	(0.2	%).	As	the	8	and	11	are	high	expressing	variants	like	the	9-repeat	variant,	8	and	11-repeats	were	combined	with	9-repeat	variants	for	further	analyses.	Again,	this	combination	 was	 justified	 by	 the	 existing	 functional	 impact	 of	 the	 variants.	 The	association	 analysis	 with	 dVNTR	 variation	 did	 not	 reveal	 any	 statistically	 significant	associations	with	the	smoking	behaviour	and	nicotine	dependence.		
Stratification of the uVNTR and dVNTR polymorphisms  Stratification	analysis	should	indicate	any	genetic	interaction	between	two	variants	that	are	 functionally	 meaningful.	 As	 previous	 studies	 indicated	 the	 interaction	 between	dVNTR	and	uVNTR	(ref)	we	decided	to	look	for	associations	within	the	subgroups	of	the	cohort	stratified	by	the	uVNTR	or	by	the	dVNTR.	The	most	common	combinations	in	our	
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cohort	were	9-3	(51.3%)	and	10-4	(40.1%)	as	predominating	haplotypes.	Combinations	9-4	(4.5%)	and	10-3	(4.1%)	were	rare	in	the	Vietnamese	cohort.	After	stratification	for	the	dVNTR	genotypes,	variations	in	the	uVNTR	genotypes	became	significant	for	several	smoking-related	phenotypes	(Tables	2	and	3).	Subjects	with	the	genotype	10	and	4	have	significantly	shorter	duration	of	smoking	(25	years,	Table	2)	by	years	 compared	 to	 subjects	with	 10	 and	 3	 repeats	 (32	 years).	 Similarly,	 subject	with	combination	between	9	and	4	had	longer	smoking	duration	than	subjects	with	9	and	3.	Similarly,	 subjects	with	10	and	3	repeats	had	significantly	higher	average	FTND	score	(4.8)	compared	to	persons	with	any	other	combination.	Interestingly,	persons	with	10	and	3	repeats	had	significantly	later	smoking	initiation	(20.3	years)	compared	to	other	combinations	(18	years).	On	the	other	hand,	persons	with	10	and	3	repeats	smoked	the	first	cigarette	in	the	morning	significantly	earlier	than	subjects	with	other	combinations.	Subjects	with	10	and	3	repeats	made	also	significantly	fewer	attempts	to	quit	(Table	2).	Almost	all	significant	finding	in	this	part	were	caused	by	the	combination	of	two	variants	that	 cause	 low	expression	 (10	 and	3)	 of	 the	MAOA	gene	 and	 this	 indicates	 functional	consequences	behind	 these	 combinations.	 Similarly,	 three	qualitative	measures	of	 the	questionnaire	were	significant	after	stratification	(Table	3).	Namely,	subjects	with	9	and	4	repeats	(high-high	combination)	had	significantly	higher	OR	to	become	a	smoker.	But	again,	subjects	with	10	and	3	repeats	felt	more	difficult	to	refrain	from	smoking	when	it	is	prohibited,	and	they	also	smoked	even	they	were	sick	in	the	bed	(Table	3).		Stratification	of	the	study	cohort	by	the	uVNTR	genotypes	confirmed	almost	all	significant	associations	we	identified	by	the	dVNTR	stratification	(Table	4).	Namely,	the	duration	of	smoking	was	longer	in	persons	with	combinations	of	the	3	and	10	or	4	and	9	(Table	4).	FTND	score	was	significantly	higher	in	subjects	with	3	and	10	repeats.	On	the	other	hand,	persons	 with	 3	 and	 10	 repeats,	 started	 smoking	 at	 later	 age	 (in	 average	 20	 years).	Subjects	with	3	and	10	combination	smoked	first	cigarette	of	the	day	earlier	than	other	combinations	and	they	made	significantly	less	quit	attempts	(Table	4).		Taken	 together,	 our	 stratification	 analysis	 identified	 significantly	 higher	 nicotine	dependence	and	significantly	higher	smoking	persistence	in	the	persons	with	the	uVNTR	3	repeat	and	dVNTR	10	repeat	combination.	Both	these	repeats	predict	low	expression	of	 the	 MAOA	 gene	 and	 therefore	 this	 combination	 is	 the	 lowest	 expression	 version	compared	to	other	variants.		 	
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Discussion 	In	the	present	study	we	analysed	two	functional	VNTRs,	likely	to	affect	MAOA	expression	in	a	tissue	specific	or	stimulus	inducible	manner,	in	the	MAOA	gene	and	their	impact	on	the	nicotine	dependence	and	smoking	behaviour.	The	MAOA	gene	has	been	recognised	to	regulate	impulse	control	and	found	to	be	involved	in	the	substance	abuse	20,	21.	The	MAOA	uVNTR	 is	 involved	 in	 the	 gene	 x	 environment	 effect	 for	 development	 of	 antisocial	personality	 disorder	 11.	 Smokers	 have	 significantly	 more	 antisocial	 characteristics	 in	their	behaviour	22.	Combination	of	the	behavioural	disorders	and	potential	for	substance	abuse,	makes	MAOA	gene	a	good	candidate	to	study	in	relation	of	nicotine	dependence.		The	cohort	consisted	of	1,804	male	subjects	of	which	1,453	were	smokers	and	369	non-smokers.	 FTND	was	used	 to	measure	 the	nicotine	dependence	 and	 two	VNTRs	 in	 the	MAOA	gene	were	genotyped	to	analyse	the	functional	variations	in	the	MAOA	gene.	FTND	is	 a	widely	 accepted	method	 to	 evaluate	 nicotine	 dependence	 and	 has	 been	 used	 for	several	decades.	Likewise,	the	VNTRs	are	recognised	as	common	polymorphisms	that	are	responsible	 for	 the	 large	 part	 of	 the	 genomic	 variation	 23.	 In	 our	 previous	 study,	 we	identified	the	interaction	between	two	VNTRs	at	the	SLC6A4	locus	in	regulating	nicotine	dependence	 16.	 This	 interaction	 reflects	 the	 functional	 reciprocal	 regulation	 of	transcriptional	activity	between	these	VNTRs	16.	Based	on	these	existing	prerequistes,	we	decided	to	test	similar	interaction	between	two	VNTRs	in	another	genetic	locus	widely	known	in	behavioural	genetics,	MAOA.		Smoking	itself	is	a	major	public	health	concern	as	it	is	a	single	major	cause	for	premature	deaths.	It	has	been	shown	that	smoking	will	reduce	the	life	expectancy	about	10	years	24.	Moreover,	long-term	smoking	causes	many	diseases	that	could	not	develop	otherwise	or	would	be	rare	in	the	general	population	24.	It	is	clear	that	reducing	prevalence	of	smoking	and	 helping	 smokers	 to	 quit	 this	 detrimental	 habit	 would	 be	 the	 easiest	 solution	 to	improve	the	quality	of	life	of	population.	However,	quitting	of	smoking	is	not	easy	and	it	has	been	estimated	 that	around	30%	of	 smokers	have	 severe	nicotine	dependence	 17.	Improved	knowledge	of	the	genetic	and	behavioural	determinants	would	help	to	develop	personalised	support	for	smoking	cessation.			
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The	 MAOA	 gene	 has	 been	 implicated	 in	 the	 genetic	 susceptibility	 for	 a	 number	 of	psychiatric	disorders	e.g.	mood	and	panic	disorders,	impulse	control	and	in	the	substance	abuse	5,	8,	25.	The	MAOA	enzyme	has	a	central	activity	in	the	biochemistry	of	monoamines	and	it	is	involved	in	the	dopamine,	serotonin	and	norepinephrine,	all	monoamines	with	fundamental	impact	on	the	regulation	of	behaviour	and	personality	9,	26.	MAOA	activity	is	variable	between	individuals	and	this	variability	is	dependent	in	part	on	the	transcription	of	the	MAOA	gene	7.	Moreover,	the	genetic	polymorphisms	(uVNTR)	can	predict	the	level	of	 metabolites	 in	 the	 CSF	 and	 this	 correlates	 with	 the	 impulsivity	 scores	 or	 delayed	response	to	the	reward	27.	Similarly,	delay	discounting	was	strongly	associated	with	the	FTND	 scores	 and	 nicotine	 dependence	 28.	 This	 behavioural	measure	 is	 considered	 to	reflect	poor	impulse	control	and	it	is	connected	with	the	difficulties	in	quitting	smoking.	MAOA	polymorphisms	are	associated	with	the	attention-deficit/hyperactivity	disorder	(ADHD),	reflecting	the	involvement	of	the	variations	in	monoamine	neurotransmission	in	the	impulse	control	29,	30.	One	larger	study	identified	uVNTR	to	be	correlated	with	the	emotional	stability	and	depression	31.	This	association	was	extended	to	the	state	anxiety	and	 impulsivity	 31.	 The	 authors	 concluded	 that	 the	 uVNTR	 in	 MAOA	 gene	 regulates	neuroticism	 and	 can	 be	 treated	 as	 a	 common	 factor	 for	 aggressive	 behaviours	 or	personality	 disorders	 31.	 On	 the	 other	 hand,	 emotional	 instability	 and	 neuroticism	 is	closely	 related	 to	 the	 smoking	 behaviour	 32.	 Finally,	 impulsivity	 disorder	 symptoms	predict	 increased	 lifetime	risk	 for	smoking	and	ADHD	symptoms	interact	with	genetic	variations	in	predicting	the	smoking	risk	30.	Therefore,	behavioural	disorders	are	closely	linked	 to	 the	 smoking	 and	nicotine	dependence	 justifying	 the	need	 to	 analyse	 similar	genetic	markers.			Existing	 literature	 supports	 the	 idea	 that	 variations	 in	 the	 MAOA	 activity	 and	polymorphisms	 in	 its	 genetic	 structure	 are	 associated	with	 the	 smoking	behaviour	 33.	More	precisely,	persons	with	certain	genetic	variants	have	higher	risk	for	the	smoking	initiation	and	persistence	34.	Most	of	the	genetic	studies	have	analysed	only	the	uVNTR	in	the	MAOA	gene	without	any	attention	to	the	variations	in	the	dVNTR.	The	main	reason	is	that	 the	 dVNTR	 has	 not	 been	 addressed	 in	 smoking	 is	 that	 only	 a	 few	 studies	 have	addressed	this	polymorphism	and	its	role	in	the	regulation	of	MAOA	in	general.	This	may	be	 due	 to	 the	 difficulty	 in	 PCR	 of	 such	 a	 rich	 GC	 repeat	 which	 required	 significant	optimisation	 in	previous	paper	when	analysed	6.	Several	 fundamental	rules	have	been	
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described	in	our	studies	for	the	dVNTR.	Firstly	the,	dVNTR	has	8,	9,	10	and	11	repeats	of	the	10-bp	motif	and	the	most	common	variants	are	9	and	10	repeats	8.	The	other	aspect	is	that	9	-repeat	is	the	most	active	in	transcriptional	regulation	and	is	more	than	10-times	more	active	 than	10-repeat	 in	cell	 line	modes.	As	a	result,	 the	9-repeat	was	 identified	clearly	as	a	high	expression	variant	8.	In	the	same	paper	much	stronger	transcriptional	influence	 of	 dVNTR	 compared	 to	 uVNTR	 was	 described.	 This	 finding	 was	 further	confirmed	in	more	detailed	functional	report	where	differential	regulation	of	uVNTR	and	dVNTR	on	alternative	isoforms	of	MAOA	was	identified	6.	Moreover,	the	dominance	of	the	dVNTR	 over	 the	 effects	 of	 uVNTR	 was	 hypothesised.	 Both	 of	 the	 mentioned	 papers	identified	clear	haplotype	structure	between	these	two	VNTRs,	with	the	9-4	and	10-3	as	the	most	dominant	versions	of	the	haplotypes	in	the	Caucasian	cohorts.		In	our	 study	we	 identified	 the	most	 common	combinations	of	 the	uVNTR	and	dVNTR	haplotypes	were	9-3	and	10-4,	that	is	different	from	Caucasian	populations	which	is	9-4	and	10-3	6.	This	finding	can	be	explained	by	the	population	differences	and	as	such	is	an	example	 to	 illustrate	 the	 importance	of	 the	population	diversity	 in	genetic	association	studies.	Despite	the	differences	in	the	haplotype	structure,	we	identified	clearly	increased	nicotine	 dependence	 and	 persistence	 of	 smoking	 behaviour	 in	 subjects	with	 the	 10-3	combination.	This	combination	predicts	low	expression	of	the	MAOA	and	low	activity	of	MAOA	 enzyme.	 This	 finding	 fits	 very	well	with	 the	 existing	 literature,	where	 the	 low	expression	genotypes	of	MAOA	were	predictive	for	increased	anti-social	behaviour	11,	35.	This	 indicates	 that	 even	 the	 basic	 haplotype	 structures	 are	 variable	 in	 different	populations,	 the	molecular	effects	 and	hence	 the	biological	outcomes	are	 comparable.	Based	on	our	study	and	previously	reported	evidence,	we	can	conclude	that	low	MAOA	activity	genotype	is	related	to	smoking	and	this	effect	is	valid	over	different	populations.		The	main	 limitation	of	present	study	 is	 the	 lack	of	data	 for	MAOB	enzyme	and	 lack	of	functional	 analyses.	 That	 could	 give	 us	 more	 comprehensive	 approach,	 but	 MAOB	analysis	was	out	of	the	scope	of	the	present	study.	Moreover,	in	case	of	MAOA	we	had	the	information	that	two	VNTR	are	interacting	to	regulate	its	activity,	but	in	case	of	MAOB	we	still	do	not	have	this	type	of	molecular	data.		Although	the	proximity	of	both	genes	to	one	another	could	suggest	that	there	may	be	some	areas	of	coordinated	expression.	
	 13	
Another	limitation	of	the	study	is	the	lack	of	any	nicotine	metabolism	measurements	and	all	 the	 analysis	 is	 based	 on	 the	 questionnaire.	 Nicotine	 metabolism	 could	 give	 more	reliable	smoking	information	but	doing	it	on	the	large	scale	is	also	challenging,	Therefore,	getting	a	larger	samples	size	was	favoured	over	the	metabolism	analysis	and	we	decided	only	to	use	questionnaire	approach.		Taken	 together	 we	 identified	 that	 in	 Asian	 population	 the	 MAOA	 VNTR	 genetic	haplotypes	have	different	distribution,	but	even	then,	we	were	able	to	identify	significant	effect	 of	 the	 MAOA	 low	 expression	 haplotype	 to	 smoking	 behaviour	 and	 nicotine	dependence.	In	conclusion,	low	MAOA	activity	is	highly	significant	risk	factor	for	smoking	in	 different	 populations	 and	 therefore	 needs	 more	 attention	 for	 the	 genetic	 studies	involving	multiple	populations.		 	
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